CTX.TO
Crescita Therapeutics Inc
Price:  
0.53 
CAD
Volume:  
25,000.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CTX.TO EV/EBITDA

-57.7%
Upside

As of 2025-05-15, the EV/EBITDA ratio of Crescita Therapeutics Inc (CTX.TO) is -0.94. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CTX.TO's latest enterprise value is 1.64 mil CAD. CTX.TO's TTM EBITDA according to its financial statements is -1.74 mil CAD. Dividing these 2 quantities gives us the above CTX.TO EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 2.3x - 9.4x 2.9x
Forward P/E multiples 1.5x - 10.1x 1.9x
Fair Price 0.23 - (0.41) 0.22
Upside -56.3% - -178.0% -57.7%
0.53 CAD
Stock Price
0.22 CAD
Fair Price

CTX.TO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-05-13 -0.94
2025-05-12 -1.16
2025-05-07 -1.27
2025-05-06 -1.49
2025-05-05 -1.16
2025-05-02 -1.49
2025-04-30 -1.49
2025-04-29 -1.49
2025-04-28 -1.49
2025-04-24 -1.38
2025-04-22 -1.38
2025-04-21 -1.27
2025-04-16 -1.60
2025-04-15 -1.70
2025-04-14 -1.49
2025-04-09 -0.94
2025-04-07 -1.05
2025-04-02 -1.27
2025-04-01 -1.49
2025-03-31 -1.49
2025-03-28 -1.49
2025-03-25 -1.49
2025-03-24 -1.60
2025-03-21 -1.27
2025-03-17 -0.83
2025-03-12 -0.72
2025-03-10 -1.16
2025-03-06 -1.16
2025-03-05 -1.60
2025-03-04 -1.38
2025-03-03 -1.38
2025-02-27 -1.27
2025-02-25 -1.27
2025-02-21 -1.27
2025-02-19 -1.27
2025-02-18 -1.27